Literature DB >> 31132231

Dietary intake of glucoraphanin prevents the reduction of dopamine transporter in the mouse striatum after repeated administration of MPTP.

Yaoyu Pu1, Youge Qu1, Lijia Chang1, Si-Ming Wang1, Kai Zhang1, Yusuke Ushida2, Hiroyuki Suganuma2, Kenji Hashimoto1.   

Abstract

AIMS: Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder. Although diet may influence the development of PD, the precise mechanisms underlying relationship between diet and PD pathology are unknown. Here, we examined whether dietary intake of glucoraphanin (GF), the precursor of a natural antioxidant sulforaphane in cruciferous vegetables, can affect the reduction of dopamine transporter (DAT) in the mouse striatum after repeated administration of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine).
METHODS: Normal food pellet or 0.1% GF food pellet was given into male mice for 28 days from 8-week-old. Subsequently, saline (5 mL/kg × 3, 2-hour interval) or MPTP (10 mg/kg × 3, 2-hour interval) was injected into mice. Immunohistochemistry of DAT in the striatum was performed 7 days after MPTP injection.
RESULTS: Repeated injections of MPTP significantly decreased the density of DAT-immunoreactivity in the mouse striatum. In contrast, dietary intake of 0.1% GF food pellet significantly protected against MPTP-induced reduction of DAT-immunoreactivity in the striatum.
CONCLUSION: This study suggests that dietary intake of GF food pellet could prevent MPTP-induced dopaminergic neurotoxicity in the striatum of adult mice. Therefore, dietary intake of GF-rich cruciferous vegetables may have beneficial effects on prevention for development of PD.
© 2019 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.

Entities:  

Keywords:  Parkinson disease; dopamine transporter; glucoraphanin; nutrition; sulforaphane

Mesh:

Substances:

Year:  2019        PMID: 31132231     DOI: 10.1002/npr2.12060

Source DB:  PubMed          Journal:  Neuropsychopharmacol Rep        ISSN: 2574-173X


  3 in total

1.  MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling.

Authors:  Atsuhiro Fujita; Yuko Fujita; Yaoyu Pu; Lijia Chang; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2019-08-15       Impact factor: 4.530

2.  Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity.

Authors:  Qianqian Cao; Qiuming Zou; Xin Zhao; Yimin Zhang; Youge Qu; Nanbu Wang; Shigeo Murayama; Qi Qi; Kenji Hashimoto; Song Lin; Ji-Chun Zhang
Journal:  Cell Death Discov       Date:  2022-05-20

Review 3.  Efficacy of Sulforaphane in Neurodegenerative Diseases.

Authors:  Giovanni Schepici; Placido Bramanti; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.